indazoles has been researched along with Brain Edema in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angerer, V; Auwärter, V; Franz, F; Jacobi, S; Pietsch, J | 1 |
| Geng, Z; Jing, Y; Liu, YL; Tian, HL; Xia, WL; Xu, ZM; Yang, DX; Yang, GY; Yuan, F | 1 |
| Lee, EJ; Lee, WT; Lin, YW; Tai, SH; Wu, TS | 1 |
| Gillessen, S; Hader, C; Rothermundt, C | 1 |
| Cheng, CY; Liu, T; Mruk, DD; Shao, J; Silvestrini, B; Wang, B; Xia, W; Xie, QR; Ying, W; Yu, H; Zhang, T | 1 |
| Morishima, Y; Sato, T; Shirasaki, Y | 1 |
| Fukunaga, K; Han, F | 1 |
1 review(s) available for indazoles and Brain Edema
| Article | Year |
|---|---|
[Brain embolism-induced injury of vascular endothelial cells and a novel vasoprotective drug].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Calmodulin; Endothelial Cells; Humans; Indazoles; Intracranial Embolism; Nitric Oxide Synthase Type III; Tyrosine | 2007 |
6 other study(ies) available for indazoles and Brain Edema
| Article | Year |
|---|---|
Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Topics: Adult; Blood Alcohol Content; Brain Edema; Cannabinoids; Chromatography, High Pressure Liquid; Designer Drugs; Humans; Indazoles; Indoles; Male; Mass Spectrometry; Pulmonary Edema; Quinolines; Substance Abuse Detection; Substance-Related Disorders; Valine | 2017 |
Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries, Traumatic; Disease Models, Animal; Hydrazines; Indazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Recovery of Function | 2018 |
YC‑1 reduces inflammatory responses by inhibiting nuclear factor‑κB translocation in mice subjected to transient focal cerebral ischemia.
Topics: Animals; Brain Edema; Brain Ischemia; Indazoles; Interleukin-1beta; Interleukin-6; Matrix Metalloproteinase 9; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2018 |
Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Axitinib; Bevacizumab; Brain Edema; Brain Neoplasms; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Lung Neoplasms; Middle Aged; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrimidines; Radiation Injuries; Sulfonamides | 2016 |
Adjudin attenuates lipopolysaccharide (LPS)- and ischemia-induced microglial activation.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Brain Edema; Brain Infarction; CD11b Antigen; Cell Line, Transformed; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hydrazines; Indazoles; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Microglia; Nervous System Diseases; NF-kappa B; Psychomotor Performance; Signal Transduction; Time Factors | 2013 |
3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier perme
Topics: Animals; Blood-Brain Barrier; Brain Edema; Calmodulin; Cell Membrane Permeability; Disease Models, Animal; Endothelium, Vascular; Indazoles; Ischemic Attack, Transient; Male; Rats; Rats, Wistar; Trifluoperazine; Water | 2003 |